CT Scan Value Of Temporal Bone In Assessment Of Congenital Deafness

Background:. Computed tomography (CT) of the temporal bone is the first-line recommended imaging modality for SNHL. Because it can identify inner ear malformations that may be responsible for hearing impairment. Objectives: To demonstrate CT abnormalities encountered in children with congenital deafness and to assess the value of CT in the prediction for cochlear implantation. Also to evaluate the incidence and types of inner ear abnormalities in children with congenital deafness identified with CT scan for implantation difficulties. Patients & Methods: This is a cross sectional study carried out during the period from October 2009 to October 2010 at Baghdad medical city complex on children patients who are suffering from congenital deafness. The study included 60 patients (120 ears), 27 males and 33 females, were evaluated by CT scan of temporal bone before cochlear implants. Results: Most of the cases undergo CT scan examination were normal (80%). Enlargement of the vestibular aqueduct is most common (10% ) causes of congenital inner ear malformations, followed by cochlear malformation (8.3%) while dysplasia of lateral semicircular canal found in (3.3%) of cases. Conclusion: High resolution CT scan is recommended in all patient for pre implant analysis of temporal bone morphology due to its reliability and easy availability. CT scan is the modality provided critical information on abnormalities of the otic capsule, pneumatisation of the mastoid, middle ear abnormalities, cochlear ducts patency and vascular abnormalities- thus helping to assess the suitability of the ear for implantation, determine the side to be implanted and to find any associated abnormality which could adversely influence the surgery or post operative period

Fluorinated Benzofuran and Dihydrobenzofuran as Anti-Inflammatory and Potential Anticancer Agents

Benzofuran and 2,3-dihydrobenzofuran scaffolds are heterocycles of high value in medicinal chemistry and drug synthesis. Targeting inflammation in cancer associated with chronic inflammation is a promising therapy. In the present study, we investigated the anti-inflammatory effects of fluorinated benzofuran and dihydrobenzofuran derivatives in macrophages and in the air pouch model of inflammation, as well as their anticancer effects in the human colorectal adenocarcinoma cell line HCT116. Six of the nine compounds suppressed lipopolysaccharide-stimulated inflammation by inhibiting the expression of cyclooxygenase-2 and nitric oxide synthase 2 and decreased the secretion of the tested inflammatory mediators. Their IC50 values ranged from 1.2 to 9.04 µM for interleukin-6; from 1.5 to 19.3 µM for Chemokine (C-C) Ligand 2; from 2.4 to 5.2 µM for nitric oxide; and from 1.1 to 20.5 µM for prostaglandin E2. Three novel synthesized benzofuran compounds significantly inhibited cyclooxygenase activity. Most of these compounds showed anti-inflammatory effects in the zymosan-induced air pouch model. Because inflammation may lead to tumorigenesis, we tested the effects of these compounds on the proliferation and apoptosis of HCT116. Two compounds with difluorine, bromine, and ester or carboxylic acid groups inhibited the proliferation by approximately 70%. Inhibition of the expression of the antiapoptotic protein Bcl-2 and concentration-dependent cleavage of PARP-1, as well as DNA fragmentation by approximately 80%, were described. Analysis of the structure–activity relationship suggested that the biological effects of benzofuran derivatives are enhanced in the presence of fluorine, bromine, hydroxyl, and/or carboxyl groups. In conclusion, the designed fluorinated benzofuran and dihydrobenzofuran derivatives are efficient anti-inflammatory agents, with a promising anticancer effect and a combinatory treatment in inflammation and tumorigenesis in cancer microenvironments